SCHEMBL24709986

SCHEMBL24709986

CCC(COC)Nc1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.46
MAPK1 P28482 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PSIP1 O75475 1/20 0.41
POLB P06746 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
GAA P10253 2/20 0.39
IDO1 P14902 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24522232 0.87 L3MBTL1 (0.45) L3MBTL1MAPK1CYP1A2CYP3A4CYP2C9
SCHEMBL13626620 0.81 TAS1R3 (0.41) TAS1R3TAS1R1KMT2AMEN1GAA
SCHEMBL12674141 0.80 TAS1R3 (0.41) MAPK1POLBTAS1R3TAS1R1GAA
SCHEMBL24710213 0.79 L3MBTL1 (0.59) L3MBTL1MAPK1PSIP1POLBKMT2A
SCHEMBL12666642 0.78 POLB (0.38) MAPK1POLBTAS1R3TAS1R1KMT2A
SCHEMBL25854719 0.77 L3MBTL1 (0.49) L3MBTL1MAPK1PSIP1POLBKMT2A
SCHEMBL632881 0.75 MAPT (0.47) L3MBTL1MAPK1CYP3A4TAS1R3TAS1R1
SCHEMBL7132787 0.68 L3MBTL1 (0.48) L3MBTL1MAPK1CYP1A2CYP3A4CYP2C9
SCHEMBL632301 0.68 L3MBTL1 (0.49) L3MBTL1MAPK1CYP1A2CYP3A4CYP2C9
SCHEMBL28907686 0.67 L3MBTL1 (0.54) L3MBTL1MAPK1PSIP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261473-A1 PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-15 WO disclosed